Please provide your email address to receive an email when new articles are posted on . Methotrexate use at the pre-arthritis stage of symptoms and subclinical inflammation fails to prevent clinical ...

Subcutaneous tocilizumab, alone or with methotrexate, showed superior efficacy over methotrexate monotherapy in treating rheumatoid arthritis in Chinese patients. The trial demonstrated higher ACR20 ...

Subcutaneous tocilizumab, either as monotherapy or in combination with methotrexate, demonstrated greater efficacy than methotrexate alone and was well tolerated in patients with active rheumatoid ...

COPENHAGEN -- Methotrexate helped high-risk individuals with aching and inflamed joints, but who didn't yet have overt rheumatoid arthritis (RA), avoid that diagnosis for close to 2 years in a ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Discontinuing methotrexate for 1 week after influenza vaccination offers similar seroprotection ...

Vienna, Austria - Patients with rheumatoid arthritis (RA) who had inadequate response to a first course of methotrexate but have not had major toxicity may be good candidates for a second round of ...

Methotrexate is the gold standard of care for RA, but it can also disrupt a pregnancy. In states with strict anti-abortion laws, some women with RA cannot get their routine medication easily or ...

Pregnant female patients with rheumatoid arthritis (RA) treated with methotrexate and leflunomide within 3 months of conception faced an increased possibility of adverse pregnancy outcomes, ...

Long-term flare risk and remission rates did not differ significantly between patients with well-controlled rheumatoid arthritis who tapered vs continued methotrexate therapy. Among patients with well ...

Credit: Getty Images. Researchers evaluated the cardiovascular safety of hydroxychloroquine vs methotrexate among patients with rheumatoid arthritis. Compared with methotrexate (MTX), treatment with ...

CHICAGO -- The current mantra of hitting rheumatoid arthritis (RA) hard and early should not equate to starting patients on biologic therapies right out of the gate, a prominent RA specialist said ...